Ellen Liu1, Allison Bigeh1, Lauren Ledingham2, Laxmi Mehta3. 1. Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. 2. Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. 3. Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. Laxmi.mehta@osumc.edu.
Abstract
PURPOSE OF REVIEW: Cardiovascular disease remains the leading cause of morbidity and mortality in women. Women were historically underrepresented in landmark trials for which cardiovascular guidelines are based on and are prone to gender-specific risk factors that predispose to coronary heart disease. RECENT FINDINGS: More attention has been made on gender and pregnancy-associated risk factors such as autoimmune disorders and preeclampsia. The most recent guidelines have reflected the need to consider risk-enhancing factors that are unaccounted for in traditional risk assessment tools. As the population ages and the burden of cardiovascular disease in women increases, it is crucial to continue focusing on preventative of cardiovascular disease in women.
PURPOSE OF REVIEW: Cardiovascular disease remains the leading cause of morbidity and mortality in women. Women were historically underrepresented in landmark trials for which cardiovascular guidelines are based on and are prone to gender-specific risk factors that predispose to coronary heart disease. RECENT FINDINGS: More attention has been made on gender and pregnancy-associated risk factors such as autoimmune disorders and preeclampsia. The most recent guidelines have reflected the need to consider risk-enhancing factors that are unaccounted for in traditional risk assessment tools. As the population ages and the burden of cardiovascular disease in women increases, it is crucial to continue focusing on preventative of cardiovascular disease in women.
Authors: Michael G Nanna; Tracy Y Wang; Qun Xiang; Anne C Goldberg; Jennifer G Robinson; Veronique L Roger; Salim S Virani; Peter W F Wilson; Michael J Louie; Andrew Koren; Zhuokai Li; Eric D Peterson; Ann Marie Navar Journal: Circ Cardiovasc Qual Outcomes Date: 2019-08-16
Authors: Eric Oosenbrug; Raquel Pedercini Marinho; Jie Zhang; Susan Marzolini; Tracey J F Colella; Maureen Pakosh; Sherry L Grace Journal: Can J Cardiol Date: 2016-04-27 Impact factor: 5.223
Authors: Liz Samayoa; Sherry L Grace; Shannon Gravely; Lisa Benz Scott; Susan Marzolini; Tracey J F Colella Journal: Can J Cardiol Date: 2013-11-12 Impact factor: 5.223
Authors: Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao Journal: Circulation Date: 2021-01-27 Impact factor: 29.690
Authors: Safi U Khan; Muhammad Zia Khan; Charumathi Raghu Subramanian; Haris Riaz; Muhammad U Khan; Ahmad Naeem Lone; Muhammad Shahzeb Khan; Eve-Marie Benson; Mohamad Alkhouli; Michael J Blaha; Roger S Blumenthal; Martha Gulati; Erin D Michos Journal: JAMA Netw Open Date: 2020-05-01